These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22764582)

  • 1. Effects of tetracyclines on bones: an ambiguous question needs to be clarified.
    Cheng W; Yue Y; Fan W; Hu Y; Wang X; Pan X; Zhou X; Qin L; Zhang P
    Pharmazie; 2012 May; 67(5):457-9. PubMed ID: 22764582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracyclines inhibit rat osteoclast formation and activity in vitro and affect bone turnover in young rats in vivo.
    Zhou X; Zhang P; Zhang C; An B; Zhu Z
    Calcif Tissue Int; 2010 Feb; 86(2):163-71. PubMed ID: 20033141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate does not increase bone volume in vivo.
    O'Sullivan S; Naot D; Callon KE; Watson M; Gamble GD; Ladefoged M; Karsdal MA; Browett P; Cornish J; Grey A
    Calcif Tissue Int; 2011 Jan; 88(1):16-22. PubMed ID: 20978751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling.
    Janning C; Willbold E; Vogt C; Nellesen J; Meyer-Lindenberg A; Windhagen H; Thorey F; Witte F
    Acta Biomater; 2010 May; 6(5):1861-8. PubMed ID: 20035905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.
    Klapisz-Wolikow M; Saffar JL
    J Cell Physiol; 1996 May; 167(2):359-68. PubMed ID: 8613479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.
    Kaur M; Nagpal M; Singh M
    Curr Drug Targets; 2020; 21(16):1640-1651. PubMed ID: 32735518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.
    Holmes SG; Still K; Buttle DJ; Bishop NJ; Grabowski PS
    Bone; 2004 Aug; 35(2):471-8. PubMed ID: 15268899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone effects of cancer therapies: pros and cons.
    Silbermann R; Roodman GD
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):251-7. PubMed ID: 21768880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
    Huffer WE
    Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
    Mendoza S; Noa M; Mas R; Mendoza N
    Drugs Exp Clin Res; 2005; 31(5-6):181-91. PubMed ID: 16425974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblast function in myeloma.
    Roodman GD
    Bone; 2011 Jan; 48(1):135-40. PubMed ID: 20601285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health.
    Andrews RE; Shah KM; Wilkinson JM; Gartland A
    Bone; 2011 Oct; 49(4):717-23. PubMed ID: 21689801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.